Our partner Michael Westhoven is taking a closer look at the eyewear and eyecare industry and explains why it might be the right time to invest now.

As a result of Covid-19 and the following retail lockdowns, many investors are currently taking a cautious approach to consumer goods in general. The eyewear industry however is a good example to show that investors should look at each consumer vertical separately and understand the underlying market dynamics.
Due to the resilience of the sector as well as a strong and positive macro-outlook Livingstones eyewear client Inspecs Plc for instance was not only able to IPO successfully shortly before the first lockdown but also to successfully finance the acquisition of the leading German eyewear group Eschenbach by raising close to EUR 95 million in equity and debt and thereby turning itself into the sixth largest eyewear group in the world during the global pandemic.
Working side by side with Inspecs nominated UK stock market advisor on this project we witnessed first-hand that institutional investors are in particular attracted to the sector for the following reasons:
All of this clearly has helped to drive the valuations of listed eyewear and eyecare makers and retailers as the development of Livingstone’s global eyewear and eyecare index1 shows:

1 Included are Carl Zeiss Medtec, EssilorLuxotica, Fielmann, Gran Vision, Hoya, Inspecs, Italia Independent, JINS, National Vision, Safilo, Sunny Optical, The Cooper Companies; index is weighted and caculated on the basis of enterprise values
However, also for investors preferring non-public equities the eyewear industry offers many attractive opportunities:
If you are interested to learn more about investment opportunities in eyewear and eyecare please do not hesitate to approach. We are happy to help you sharpen your view on the industry.
Share on: